ProfFidelma Fitzpatrick
Professor/Consultant Microbiologist
Clinical Microbiology
- Professor/Consultant MicrobiologistClinical Microbiology
- RCSI Smurfit Building Beaumont Hospital, Clinical Microbiology, Dublin 9, Ireland
IMPACT AND ENGAGEMENT OVERVIEW
Prof Fidelma Fitzpatrick's work has helped shape infection prevention, antimicrobial stewardship and healthcare-associated infection policy in Ireland over the past two decades. Her career has spanned clinical practice, public health, research, education and healthcare leadership, with a particular focus on healthcare-associated infections, antimicrobial resistance (AMR), Clostridioides difficile infection and sepsis.
Working nationally through the Health Protection Surveillance Centre (HPSC) and the Health Service Executive (HSE), she led Ireland's first prevalence studies of healthcare-associated infections in hospitals and long-term care facilities, established national C. difficile surveillance, chaired national guideline groups, and contributed to the development of programmes and policies that continue to inform clinical practice today.
As Chair of the National Sepsis Steering Group since 2013, Prof Fitzpatrick has supported the development of Ireland's national approach to sepsis care. She has also worked to ensure that antimicrobial stewardship and AMR prevention are embedded within sepsis policy and practice.
At Beaumont Hospital and RCSI, her research and quality improvement work focus on reducing healthcare-associated infections, sepsis and antimicrobial resistance. During the COVID-19 pandemic, she played a key leadership role in supporting hospital and university responses and translating emerging evidence into practice.
Prof Fitzpatrick has published more than 240 peer-reviewed papers, which have been cited over 6,000 times. Her research has informed national and international guidelines and has contributed to improvements in infection prevention, antimicrobial stewardship and patient safety.
She is also committed to developing the next generation of healthcare professionals through teaching, curriculum development, mentorship and postgraduate training. Her work has helped create opportunities for clinicians, researchers and trainees to build expertise and leadership skills in infection prevention and clinical microbiology.
Her contributions have been recognised nationally and internationally, including election to the Executive Committee of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in 2024 and the award of an ESCMID Fellowship, one of the Society's highest honours.